• Mashup Score: 6

    Tricuspid regurgitation (TR) is a highly prevalent valve disorder in the US, with prevalence increasing with age. Without treatment, severe TR carries a poor

    Tweet Tweets with this article
    • 🌟New #USCardiology Review out‼️ "Transcatheter Tricuspid Valve Replacement: Case Selection, Technical Considerations, and Procedural Planning" by @asimshabbir54 @Pooh_Velagapudi et al. 🔗https://t.co/pgmDfLcun2 https://t.co/038brzUGQd

    • Nice review by Dr. @asimshabbir54 on ‘Transcatheter Tricuspid Valve Replacement: Case Selection, Technical Considerations, and Procedural Planning’ for USCJournal… Thanks to Dr. @PradeepYadavMD & #NidhishTiwari for their huge contribution towards this! https://t.co/UFdryLq25E

  • Mashup Score: 9

    Author links open overlay panel Poonam Velagapudi MD, MS a, Ajay J. Kirtane MD, SM b, Jacqueline Saw MD c Dr Velagapudi is on the Speakers Bureau and has received speaking fees from Abiomed, Medtronic, Opsens, and Shockwave Medical; and was on the advisory board for Abiomed and Sanofi. Dr Kirtane has received institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Amgen, CSI, Philips, ReCor Medical, Neurotronic, Biotronik,

    Tweet Tweets with this article
    • Check out our editorial in #JACCInterventions discussing an interesting manuscript “PPCI in Patients With #SCAD vs CAD” by Alfonso et al. Editorial: “SCAD Causing AMI: Is Revascularization the Best Course of Action?” 👉https://t.co/yR4fGAoZKE @JACCJournals @docsaw #AjayKirtane